NCT00121043View on ClinicalTrials.gov

Evaluating Kineret® (Anakinra) in Rheumatoid Arthritis (RA) Subjects Using aSelf-Reported Questionnaire

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Rheumatoid Arthritis
Interventions
DEVICE

SimpleJectTM

DRUG

Kineret® (Anakinra)

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT00121043 - Evaluating Kineret® (Anakinra) in Rheumatoid Arthritis (RA) Subjects Using aSelf-Reported Questionnaire | Biotech Hunter | Biotech Hunter